National Cancer Institute; Notice of Meeting

Download PDF
Federal RegisterOct 14, 2004
69 Fed. Reg. 61027 (Oct. 14, 2004)

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Cancer Institute Director's Consumer Liaison Group.

The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

Name of Committee: National Cancer Institute Director's Consumer Liaison Group.

Date: November 4, 2004.

Time: 3 p.m. to 4:45 p.m.

Agenda: Report from NCI Listens and Learns Operations Working Group/Discussion; Report from NCI Listens and Learns Promotions Working Group/Discussion; Report from NCI Listens and Learns Summit Working Group/Discussion; Report from NCI Listens and Learns Evaluation Working Group/Discussion; Next Steps.

Place: National Institutes of Health, National Cancer Institute, 6116 Executive Boulevard, Suite 220, Bethesda, MD 20892 (Telephone Conference Call).

Contact Person: Nancy Caliman, Executive Secretary, Office of Liaison Activities, National Institutes of Health, National Cancer Institute, 6116 Executive Boulevard, Suite 220, MSC8324, Bethesda, MD 20892, (301) 496-0307, calimann@mail.nih.gov.

Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute's/Center's home page: http://deainfo.nci.nih.gov/advisory/dclg/dclg.htm,, where an agenda and any additional information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support, 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: October 5, 2004.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 04-23002 Filed 10-13-04; 8:45 am]

BILLING CODE 4140-01-M